🇪🇺 Remicade in European Union

EMA authorised Remicade on 13 August 1999

Marketing authorisation

EMA — authorised 13 August 1999

  • Status: approved

Remicade in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Remicade approved in European Union?

Yes. EMA authorised it on 13 August 1999.

Who is the marketing authorisation holder for Remicade in European Union?

Johnson & Johnson is the originator. The local marketing authorisation holder may differ — check the official source linked above.